Breast cancer not linked to bras
the ONA take:
According to a new study published in Cancer Epidemiology, Biomarkers, and Prevention, wearing bras does not increase a woman's risk for developing breast cancer. In the study, researchers identified more than 1,000 postmenopausal women with invasive breast cancer and about 450 women without cancer.
Among other things, women were asked about their lifetime patterns of bra use during face-to-face interviews. Researchers analyzed the data and found that there was no association between bra use and the development of breast cancer.
There has previously been no data indicating that wearing a bra is linked to developing breast cancer, but a book entitled "Dressed to Kill: The Link Between Breast Cancer and Bras," which was published in 1995, started the widespread rumors that there is an association. The book proposed that women of Western cultures had an increased risk of breast cancer compared with indigenous cultures because Western women wear bras. The study was widely criticized for its poor study design.
This new case-control study conducted by the Fred Hutchinson Cancer Research Center in Seattle, Washington, now puts to rest the myths surrounding wearing bras and developing breast cancer.
Wearing bras does not increase a woman's risk for developing breast cancer.
It's official, you can wear a bra without increasing your risk of developing breast cancer. Despite there being no scientifically valid data indicating that wearing a bra causes cancer, there have been widespread rumours to the contrary.
They were started in 1995 by the book “Dressed to Kill: The Link Between Breast Cancer and Bras,” The authors suggested that the increased risk of breast cancer in Western cultures compared with indigenous cultures was due to wearing bras. However, the research methodology was criticized for having a range of design flaws, including not adjusting for known breast cancer risks such as weight and age, but Western women continued to worry.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|